Old Web
English
Sign In
Acemap
>
authorDetail
>
J. E. Rangel
J. E. Rangel
Medicine
Physical therapy
Cisplatin
Gemcitabine
Lung cancer
3
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Interim analysis of the triplet association cisplatin (P), gemcitabine (G) and vinorelbine(V) for advanced small cell lung cancer (SCLC)
2006
Journal of Clinical Oncology
B. M. Eyll
J. R. Pereira
J. Y. Yamaguchi
M. T. Arruda
F. S. Feio
C. M. Costa
M. A. Melo
J. E. Rangel
A. P. Santana
C. M Almeida
Show All
Source
Cite
Save
Citations (0)
Cisplatin plus gemcitabine third-line chemotherapy for NSCLC after failure to cisplatin and gemcitabine in separated schedules
2005
Journal of Clinical Oncology
B. M. Eyll
J. R. Pereira
M. T. Arruda
J. Y. Yamaguchi
J. E. Rangel
A.J. Santana
C. Mesquita
F. M. Feio
Show All
Source
Cite
Save
Citations (2)
Comparative retrospective study between best supportive care (BSC) versus chemotherapy for elderly patients with NSCLC
2004
Journal of Clinical Oncology
A. V. Katz
M. T. Arruda
J. Y. Yamaguchi
J. E. Rangel
C. M Almeida
J. R. Pereira
Show All
Source
Cite
Save
Citations (1)
1